| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 1999;30:2073-2085.)
© 1999 American Heart Association, Inc.
Original Contributions |
From the Departments of Radiology, Division of Interventional Neurovascular Radiology (A.M.M., R.T.H., C.C.P., T.E.L., P.M.M., C.F.D., V.V.H.), Neurological Surgery (R.T.H., C.F.D., V.V.H.), and Neurology (D.R.G.), University of California, San Francisco.
Correspondence and reprint requests to Adel M. Malek, MD, PhD, Department of Neurosurgery, Children's Hospital, Bader 3, 300 Longwood Ave, Boston, MA 02115. E-mail ammalek{at}bics.bwh.harvard.edu
| Abstract |
|---|
|
|
|---|
MethodsTwenty-one patients (9 female, 12 male) with a mean age of 65.7 years (range 47 to 81 years) underwent treatment with percutaneous endovascular balloon angioplasty and stent placement. Sixteen patients (76.2%) had evidence of contralateral involvement, and 9 (42.8%) demonstrated severe anterior-circulation atherosclerosis. Nine patients had a previous infarct in the occipital lobe, cerebellum, or pons before treatment. Follow-up was available for all patients.
ResultsBalloon angioplasty with intravascular stent placement was performed in 13 vertebral artery lesions (10 at the origin, 3 in the cervical segment) and in 8 subclavian lesions. The prestenting stenosis was 75% (50% to 100%) and was reduced to 4.5% (0% to 20%) after stenting. Six of the patients with proximal subclavian stenosis demonstrated angiographic evidence of subclavian steal, which resolved in all cases after treatment. All patients showed improvement in symptoms after the procedure except for 1 who developed a hemispheric stroke after thrombotic occlusion of an untreated cavernous carotid artery stenosis (rate of major stroke and mortality=4.8%). One patient (4.8%) had a periprocedural transient ischemic attack (TIA), and none had minor stroke. At long-term follow-up (mean=20.7±3.6 months) of the surviving 20 patients, 12 (57.1%) remained symptom-free, 4 (19%) had at most 1 TIA over a 3-month period, 2 (9.5%) had at most 1 TIA per month, and 2 (9.5%) had persistent symptoms. There were no clinically evident infarcts during the follow-up period.
ConclusionsEndovascular treatment using balloon angioplasty with intravascular stent placement for symptomatic stenotic lesions resulting in VBI that is unresponsive to medical therapy appears to be of benefit in this high-risk subset of patients with poor collateral flow.
Key Words: angioplasty, balloon atherosclerosis stenosis stents subclavian steal syndrome vertebrobasilar insufficiency
| Introduction |
|---|
|
|
|---|
| Subjects and Methods |
|---|
|
|
|---|
Procedure
A baseline angiographic study was performed of the bilateral
subclavian, vertebral, and carotid arteries to determine the extent of
vascular disease and presence of collateral circulation. An
activated clotting time (ACT) was obtained before onset of the
angiographic procedure. The patient was given a weight-adjusted bolus
of intravenous heparin 70 U/kg body wt followed by either
an hourly bolus of heparin 35 U/kg body wt or a continuous infusion of
15 U · kg body wt-1 ·
h-1. The ACT was obtained after initial heparin
bolus to ensure a value greater than twice baseline ACT, or >250
seconds. The patients then underwent the procedure either under
monitored anesthesia care with short-acting
intravenous sedation or under general endotracheal
anesthesia. Vascular access was obtained via a single-wall
puncture of either the common femoral artery (n=19) or the ipsilateral
brachial artery (n=2, patients 5 and 8). A 7F to 9F access sheath was
used (Avanti, Cordis Endovascular Systems). A guide catheter (Brite
Tip, Cordis) was then carefully placed into the aortic arch or
innominate artery for treatment of the proximal left or right
subclavian lesions or in the subclavian artery proximal to the
vertebral artery origin. The lesion was then traversed either with a
0.035-in exchange wire (Storq, Cordis) or a combination of a 3.2F
microcatheter (Rapid Transit, Cordis) and an exchange microguidewire
(Stabilizer 300 cm, Cordis). In the case of severe stenosis
(80%), an angioplasty balloon catheter was used to predilate the
lesion to allow subsequent passage of a balloon-mounted or
self-expanding stent. In cases of milder stenosis (50% to
60%), such as in the case of intimal dissection, primary stenting was
performed with either a self-expanding stent (WallStent, Schneider), a
balloon-mounted stent (Palmaz, Johnson & Johnson), or a
balloon-premounted stent (GFX, Arterial Vascular
Engineering). After insertion of the stent and before deployment, an
angiographic acquisition was performed to ascertain accurate location
of the stent across the stenotic lesion. Postdeployment
high-pressure balloon angioplasty (12 to 21 atm) was subsequently
performed if needed. The intravenous heparin administration
was either halted at the end of the procedure without reversal or
maintained overnight for 12 hours. The patients were placed on an oral
regimen of ticlopidine (250 mg PO BID) or clopidogrel (75 mg PO QD) for
6 weeks and on indefinite aspirin (325 mg PO QD). Certain patients who
had either known severe stenosis in other vessels or
concomitant severe intracranial atherosclerosis were
maintained on oral warfarin therapy.
Outcome
Neurological outcome was determined at the longest duration of
follow-up according to a 5-point scale as follows: excellent (score=1,
asymptomatic, no neurological deficits and no symptoms of
vertebrobasilar ischemia), good (score=2, no neurological
deficits and at most 1 transient episode of vertebrobasilar
ischemia over a period of 3 months after treatment), fair
(score=3, minimal neurological deficit and at most 1 transient episode
per month of vertebrobasilar ischemia), poor (score=4, no
improvement compared with neurological status before treatment and/or
persistent symptoms of vertebrobasilar ischemia), and death
(score=5, regardless of cause).
Quantitative Analysis and Statistics
Severity of stenosis was computed according to the
NASCET criteria with dimensions obtained either from the fluorographic
appearance of a reference object or via the angiography digital
computer system (Toshiba).11 Specifically, the diameter of
maximal stenosis (DStenosis) was
measured along with the most proximal diameter of the distal normal
vessel (DNormal), and the degree of
stenosis was computed as
stenosis=[1-(DStenosis/DNormal)]x100.11
The paired Student's t test and ANOVA were used in the
comparison of numerical variables. A logarithmic transformation of
the outcome score was performed before statistical analysis to
minimize variability in variance among subgroups. For categorical
analysis, a Pearson's
2 test was
used. Statistical significance was assumed for a value of
P<0.05.
| Results |
|---|
|
|
|---|
|
|
Lesion Characteristics
The lesions treated were left-sided in 14 and right-sided in 7
cases (Table 2
). The mean stenosis was 78.7±3.5% on
left-sided and 68.6±5.1% on right-sided lesions (Figure 2
). Nine patients (42.8%) had
simultaneous unilateral or bilateral carotid
stenosis of >60%, and 3 had unilateral or bilateral carotid
occlusion (14.3%). Contralateral vertebral or subclavian occlusion or
significant stenosis was encountered in 16 of 21 patients
(76.2%). The location of the stenotic lesions treated in this
cohort was as follows: 10 lesions (47.6%) at the origin of the
vertebral artery, 3 (14.3%) at the midcervical vertebral artery, and 8
(38%) in the subclavian artery proximal to the vertebral artery
origin. Of the 8 patients presenting with subclavian
stenosis, 6 (75%) demonstrated subclavian steal, with
retrograde flow in the vertebral artery ipsilateral to the
stenosis. All 6 of these patients had resolution of the
angiographic steal syndrome by the stent and angioplasty procedure
(100%). The mean lesion stenosis before treatment was
75.2±14.1% and was decreased to a final value of 4.8±1.6%
(P<0.001) after both angioplasty and stent deployment
(Figure 3
).
|
|
|
Procedure-Related Complications
The procedure-related mortality was 4.8%, and morbidity was 9.5%
(Table 3
). There was 1 TIA within 24 hours of the procedure
(patient 12). There were no minor or major strokes related to the
territory treated during the procedure (0%), although the rate of
overall major stroke was 4.8% (patient 8). Intimal dissection
resulting from angioplasty was encountered in 7 procedures, 5 of which
were treated by additional stent deployment; 2 cases (patients 12 and
18) in which the dissection was minimal and not flow-limiting had no
further treatment.
|
There were 3 complications. One patient with a known severe, left cavernous internal carotid artery stenosis (>95%) (patient 8) underwent successful stent placement in the left subclavian and vertebral arteries with an uneventful immediate postprocedural course but developed acute thrombotic occlusion of the left internal carotid artery. Despite emergent angiography and superselective infusion of urokinase, the occlusion could not be recanalized. The patient developed a major hemispheric stroke and died after withdrawal of support. The second complication consisted of a stent infection at 10 days after successful deployment (patient 21); the source of infection was presumed to be phlebitis from an ipsilateral distal infected intravenous site. The ensuing arteritis required surgical removal of the stent and bypass grafting of the left vertebral artery; the patient had no neurological sequelae. The third complication (patient 5) resulted from mild thrombocytopenia (platelet count of 68 000/mm3) after discharge from the hospital, which resolved with discontinuation of ticlopidine.
Clinical Outcome
Neurological outcome was determined immediately after the
procedure, at 30 days, and at latest follow-up (mean of 20.7±3.6
months). The majority of patients (20 of 21, 95.2%) were
symptomatic and experienced either improvement in their
posterior-circulation symptoms or no further episodes of
ischemia after the procedure, except for 1 patient who
developed a transient arm weakness that resolved within 24 hours (1 of
21, 4.8%) (Figure 4
). At 30 days,
neurological outcome was excellent in 13 patients (61.9%) and good in
7 patients (33.3%), and 1 patient (4.8%) died. At latest follow-up,
the neurological outcome was excellent in 12 patients (57.1%), good in
4 patients (19%), fair in 2 patients (9.5%), and poor in 2 patients
(9.5%), and 1 patient (4.8%) died. There were no clinically evident
strokes in the posterior-circulation territory during the entire
follow-up period. Assessment of symptom-free status (neurological
score=1) revealed it to be inversely correlated with contralateral
disease (
2=6.3, P<0.012), carotid
occlusion (
2=4.7, P<0.03), and
anterior-circulation atherosclerosis
(
2=7.8, P<0.005).
Moderate carotid stenosis (<60%) and sex were not correlated
with outcome.
|
Ultrasonographic or angiographic follow-up was obtained in 12 of the surviving 20 patients. Three of the 10 patients had evidence of mild-to-moderate restenosis, 1 had severe intimal hyperplasia, and 1 had complete occlusion at 1 year (patient 10). This occurred in a patient with obliterative vasculopathy and concomitant occlusion of the left internal carotid artery, contralateral subclavian artery, and bilateral common femoral artery stenoses.
Illustrative Cases
Patient 9
A 52-year-old right-handed man with coronary artery
disease and previous radiation therapy for a mediastinal tumor
developed a stroke after noting sudden diplopia, left leg weakness, and
dysarthric speech. An angiogram showed bilateral subclavian artery
occlusions, with >90% stenosis of the left vertebral artery
origin (Figure 5
). An MR scan revealed a
left pontine infarct. The patient was given intravenous
anticoagulation with heparin, converted to warfarin, and discharged.
Three days later, he had another episode of diplopia with worsening
speech and left hemiparesis despite therapeutic anticoagulation. The
patient was transferred to our institution 2 months after his infarct.
On examination, he was dysarthric and had a right-sided internuclear
ophthalmoplegia and decreased sensation in the left V2 distribution
with flattening of the left nasolabial fold. His motor examination
revealed weakness in both upper (4/5) and lower (4/5,
proximal greater than distal) extremities. Repeat angiography revealed,
in addition to the previously noted occlusion of right subclavian
origin, a new complete occlusion of the left vertebral artery origin.
This vessel had been patent though stenotic in the angiogram
performed 2 months before admission. Closer inspection revealed the
distal left vertebral artery to be reconstituted at the C4 vertebral
level via muscular branch collaterals of the thyrocervical trunk. Late
venous-phase angiography showed retrograde stasis of the contrast
column down to within 1 cm of the left subclavian artery. A
microguidewire and catheter were navigated into the very proximal left
vertebral artery, where a small test injection confirmed intraluminal
placement without intimal dissection. With the microcatheter in this
position, 250 000 U urokinase was administered over a period of 15
minutes. A balloon angioplasty catheter (4x20 mm Powerflex,
Cordis) was used to dilate the origin, with an inflation of 13 atm of
pressure. Postangioplasty angiography revealed persistent
stenosis of the origin, suggesting lesion recoil. A Palmaz
stent, mounted on an angioplasty balloon (5x20 mm Powerflex,
Cordis) was therefore deployed across the residual stenosis.
Posttreatment angiography showed excellent restoration of antegrade
flow in the left vertebral artery with complete patency of the
vertebral artery origin to its normal native diameter. Injection of the
left subclavian artery showed excellent antegrade flow to the distal
basilar, posterior cerebral, and superior cerebellar arteries, with
retrograde flow into the right vertebral artery. The patient was
maintained on heparin, was converted to warfarin, and was able to
ambulate on his own on postprocedure day 3. He was discharged home the
next day. He has shown good recovery from his left hemiparesis and
ophthalmoplegia and has had no further neurological episodes at 26
months of follow-up. Ultrasound follow-up at 24 months confirms
anterograde flow in the left cervical vertebral artery.
|
Patient 7
A 68-year-old right-handed man with coronary artery
disease, a history of 60-pack-year smoking, and laryngeal cancer status
postradiation therapy noticed an increase in the frequency of episodes
of orthostatic dizziness, visual changes, and subjective
heaviness in the arms and legs lasting
30 seconds. The patient
underwent cerebral angiography, which revealed bilateral occlusions of
the internal carotid arteries (Figure 6
)
at the origin. The right vertebral artery was irregular in contour, and
the left showed a 1-cm segment of irregular caliber at its origin and a
more distal stenosis. The patient was placed on oral
anticoagulant therapy but showed no improvement in symptoms after a
period of 3 months. Given the lack of response to medical therapy and
the extensive carotid occlusive disease, a decision was made to treat
the vertebral artery stenosis. A microguidewire and catheter
were used to cross the left vertebral artery stenosis, which
underwent balloon dilatation of the proximal and distal
stenoses. This was followed by deployment of a self-expanding
WallStent (5x40 mm) into the left vertebral artery origin, thus
covering both stenoses. Postdeployment angiography revealed
complete reconstitution of the vessel lumen, with evidence of normal
distal perfusion. Injection of the left subclavian artery now showed
filling of the bilateral anterior cerebral arteries from the left
vertebral artery via a patent left posterior communicating artery
(Figure 6G
). The patient tolerated the procedure with no
neurological deficits and was discharged on postprocedure day 4 on oral
warfarin therapy. Despite angiographic improvement in the left
vertebral flow and in posterior-circulation perfusion, the patient
later complained of recurrent TIAs, stereotyped by loss of vision,
blank stare with open eyes, followed by an unresponsive state lasting
seconds to minutes. These attacks were different from the ones noted
before the procedure because of their orthostatic
independence. An ambulatory EEG was negative, but a Holter monitor
showed a 9-second pause, for which the patient underwent placement of a
VDD pacemaker.
|
Patient 18
A 53-year-old right-handed man with hypertension,
hyperlipidemia, and status post C4-5 and C5-6 cervical
fusion presented 14 months before admission with transient
ischemic episodes consisting of visual field deficits. He was
treated with aspirin but developed a stroke in the right occipital lobe
2 months later, which left a residual left lower quadrantanopia.
The patient was placed on warfarin after MR angiography, and a
conventional angiogram disclosed the presence of a highly
stenotic and irregular lesion in the proximal left vertebral
artery origin (Figure 7
). Repeat
angiography 7 months later revealed worsening in the stenosis
and irregularity of the left vertebral artery origin. Consequently, an
endovascular approach was undertaken to revascularize the left
vertebral origin stenosis. A 7F guide catheter was placed in
the left subclavian artery, and an AVE stent (GFX 4x18 mm) was
positioned primarily across the lesion and deployed by balloon
inflation to 9 atm (Figure 6
). Poststent angiography revealed
improved flow to the distal vertebral artery and posterior circulation.
The patient was discharged on antiplatelet therapy and has remained
asymptomatic at 4 months of neurological follow-up.
|
Patient 17
An 81-year-old 60-pack-year female smoker with hypertension,
diabetes mellitus, and peripheral vascular disease who had
had 2 previous aortofemoral bypass graft procedures began to have
increasing episodes of orthostatic lightheadedness and
dizziness. A vascular ultrasound of the cervical vessels disclosed the
finding of bidirectional flow in the left vertebral artery
consistent with left subclavian steal syndrome. The patient
underwent diagnostic angiography showing 65%
stenosis of the left subclavian artery proximal to the origin
of the left vertebral artery (Figure 8
).
The left vertebral artery was nondominant and exhibited weak
anterograde opacification, followed by retrograde flow in the
late phase of the subclavian contrast injection, a phenomenon
consistent with a left subclavian steal. A Palmaz stent was
mounted on an angioplasty balloon catheter (Powerflex 7x20 mm,
Cordis) and advanced across the lesion. Poststent angiography revealed
resolution of the stenosis in the left subclavian artery origin
with excellent anterograde flow in the hypoplastic left
vertebral artery and resolution of the steal phenomenon. The patient
noted immediate improvement in her symptoms after the procedure and has
remained asymptomatic at 8 months of
follow-up.
|
| Discussion |
|---|
|
|
|---|
The paucity of collateral flow in the patient population treated in the present study is underlined by the extent of bilateral vertebral or subclavian stenosis or occlusion and anterior-circulation disease. Accordingly, among the 8 patients treated who presented with subclavian steal, 4 had bilateral disease and 2 of the remaining 4 had developed an artery-to-artery embolus in the posterior circulation. This is an important characteristic, because the subclavian steal phenomenon in itself has previously been reported to be relatively benign and perhaps not to warrant aggressive surgical or interventional treatment when not symptomatic or not associated with hemodynamic spells.3 17
Although percutaneous balloon angioplasty alone has
been used in the treatment of vertebral-origin stenosis, there
has been increasing impetus to use intravascular stents because of the
frequent observation of vessel recoil and restenosis after
unsupported angioplasty,4 as illustrated in Figure 5
(compare Figure 5G
and 5H
). Results from a number of
studies evaluating the use of stents in the carotid artery have
suggested that it may be useful in a subset of patients with very high
medical risk or in patients with tandem lesions or bilateral carotid
stenosis.18 19 Although surgical repair of the
vertebral artery origin and subclavian artery has been performed with
excellent results by centers with large experience, it is technically
more difficult and has less well defined outcomes in the patient cohort
described in the present study, namely, patients with poor
collateral flow with a high proportion of bilateral
vertebral/subclavian and coexistent carotid
disease.14 20 21 22 Surgical treatment has consisted of
either ostial vertebral endarterectomy, subclavian
endarterectomy, or reimplantation of the vertebral
artery in the subclavian or carotid artery. In their series of 325
lesions treated surgically in 290 patients, Thevenet and
Ruotolo20 described a low mortality of only 0.6%. Only
13.8% of lesions in that series were bilateral, compared with 76.2%
in our patient population. Furthermore, surgical repair was associated
with a relatively high rate of postoperative Horner's syndrome (28%),
a complication we did not encounter. At long-term follow-up, 68% of
patients were asymptomatic, compared with 57% in our
group. In the case of subclavian stenosis, surgical bypass
procedures and carotid-subclavian bypass grafting have been surgically
offered. Although they have been reported to have good long-term
outcome, they are associated with a relatively high rate of
perioperative morbidity, ranging up to
18%.14 21 22
Conclusions
The results in this clinical retrospective series, the largest to
date, point to endovascular balloon angioplasty and stent placement as
a useful technique for the treatment of vertebrobasilar territory
ischemia in patients who have failed best medical therapy.
Although long-term angiographic follow-up will be needed to assess the
durability of stent patency, the clinical outcome in this patient
group, with a high proportion of contralateral and anterior-circulation
disease, suggests a sustained benefit of the procedure.
|
| Acknowledgments |
|---|
Received May 25, 1999; revision received July 19, 1999; accepted July 22, 1999.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
F. Siddiq, G. Vazquez, M. Z. Memon, M. F. K. Suri, R. A. Taylor, J. C. Wojak, J. C. Chaloupka, and A. I. Qureshi Comparison of Primary Angioplasty With Stent Placement for Treating Symptomatic Intracranial Atherosclerotic Diseases: A Multicenter Study Stroke, September 1, 2008; 39(9): 2505 - 2510. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Coward, D. J.H. McCabe, J. Ederle, R. L. Featherstone, A. Clifton, M. M. Brown, and on behalf of the CAVATAS Investigators Long-Term Outcome After Angioplasty and Stenting for Symptomatic Vertebral Artery Stenosis Compared With Medical Treatment in the Carotid And Vertebral Artery Transluminal Angioplasty Study (CAVATAS): A Randomized Trial Stroke, May 1, 2007; 38(5): 1526 - 1530. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Kantarci, I. Mihmanli, M. S. Albayram, H. Barutca, F. Gulsen, N. Kocer, and C. Islak Follow-up of extracranial vertebral artery stents with Doppler sonography. Am. J. Roentgenol., September 1, 2006; 187(3): 779 - 787. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Sacco, R. Adams, G. Albers, M. J. Alberts, O. Benavente, K. Furie, L. B. Goldstein, P. Gorelick, J. Halperin, R. Harbaugh, et al. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Circulation, March 14, 2006; 113(10): e409 - e449. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Sacco, R. Adams, G. Albers, M. J. Alberts, O. Benavente, K. Furie, L. B. Goldstein, P. Gorelick, J. Halperin, R. Harbaugh, et al. Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Stroke, February 1, 2006; 37(2): 577 - 617. [Abstract] [Full Text] [PDF] |
||||
![]() |
Intracranial Angioplasty & Stenting for Cerebral Atherosclerosis: A Position Statement of the American Society of Interventional and Therapeutic Neuroradiology, Society of Interventional Radiology, and the American Society of Neuroradiology AJNR Am. J. Neuroradiol., October 1, 2005; 26(9): 2323 - 2327. [Full Text] [PDF] |
||||
![]() |
C.-P. Liu, Y.-H. Ling, and H.-L. Kao Use of a Pressure-Sensing Wire to Detect Sequential Pressure Gradients for Ipsilateral Vertebral and Subclavian Artery Stenoses AJNR Am. J. Neuroradiol., August 1, 2005; 26(7): 1810 - 1812. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Higashida, P. M. Meyers, C. C. Phatouros, J. J. Connors III, J. D. Barr, D. Sacks, and for the Technology Assessment Committees of the Am Reporting Standards for Carotid Artery Angioplasty and Stent Placement Stroke, May 1, 2004; 35(5): e112 - e134. [Full Text] [PDF] |
||||
![]() |
D. D. M. Lin, P. Gailloud, N. J. Beauchamp, E. M. Aldrich, R. J. Wityk, and K. J. Murphy Combined Stent Placement and Thrombolysis in Acute Vertebrobasilar Ischemic Stroke AJNR Am. J. Neuroradiol., October 1, 2003; 24(9): 1827 - 1833. [Abstract] [Full Text] [PDF] |
||||
![]() |
G C Cloud, F Crawley, A Clifton, D J H McCabe, M M Brown, and H S Markus Vertebral artery origin angioplasty and primary stenting: safety and restenosis rates in a prospective series J. Neurol. Neurosurg. Psychiatry, May 1, 2003; 74(5): 586 - 590. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.C. Cloud and H.S. Markus Diagnosis and management of vertebral artery stenosis QJM, January 1, 2003; 96(1): 27 - 54. [Full Text] [PDF] |
||||